There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Edwards Lifescienes also reported a big increase in pay for the structural heart device developer and manufacturer's median ...

Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $76.89, a high estimate of ...

Career Achievement Award will be presented to Stephan Windecker, MD, during Transcatheter Cardiovascular Therapeutics® (TCT®) ...